35
Participants
Start Date
October 11, 2016
Primary Completion Date
April 26, 2017
Study Completion Date
April 26, 2017
vasoplegic syndrome
Patients with vasoplegic syndrome for whom the intensive care physician planned to decrease the norepinephrine dosage were included. Hemodynamic and uncalibrated pulse contour analysis (Volume view, FloTrac, Edwards Lifescience, Irvine) values were obtained before and after decreasing the norepineprhine dosage. Responders were defined by a \>10% decrease in mean arterial pressure (MAP).
Centre Hospitalier Universitaire, Amiens
OTHER